{"store":{"baseInfo":{"podcastTitle":"The HemOnc Pulse","slug":"hemoncpulse","podcastDescription":"Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Rahul Banerjee, MD, covering all topics in the world of hematologic oncology.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","podcastUrl":"https://hemoncpulse.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/hemoncpulse/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pw/pbblog-gbcct-110b233?from=usersite","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":65,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Rahul Banerjee, MD","enableEngagementStats":true,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-gbcct-110b233-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://www.podbean.com/pw/pbblog-gbcct-110b233?from=usersite","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/r1zV1nCvRuqN","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-W6nWPbI0puz9","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2025 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"userLikeCheckedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://hemoncpulse.podbean.com","apiCommonParams":{"t":"68629838","clientSignature":"3f6688c95a23692a19db7b37894acd3a","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb23144895-rhkkv","episode":{"id":"pb23144895","idTag":"rhkkv","title":"Discussing the Role of MRD in CLL With Talal Hilal, MD","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","previewContent":null,"content":"

Dr. Hilal, of the Mayo Clinic, joins Chadi Nabhan, MD, MBA, FACP, on “The HemOnc Pulse” to discuss measurable residual disease (MRD) and the debates surrounding its use for response assessment in patients with chronic lymphocytic leukemia (CLL).

","publishTimestamp":1715842800,"duration":1298,"mediaUrl":"https://mcdn.podbean.com/mf/web/uqqh7qpi3i7m4vf8/Tal_Hillal_CLL_edited_finala2dop.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-rhkkv-16129bf","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-rhkkv-16129bf","transcriptUrl":null,"permalink":"/e/talal-hilal-md-on-mrd-controversies-in-cll/","downloadLink":"https://www.podbean.com/media/share/pb-rhkkv-16129bf?download=1","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":311,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-rhkkv-16129bf","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false,"userIdEncrypted":null,"userProfilePicture":null,"username":null,"isVerified":false,"loadUserInfo":false,"loginUrl":"https://www.podbean.com/site/user/login?return=https%253A%252F%252Fhemoncpulse.podbean.com%252Fe%252Ftalal-hilal-md-on-mrd-controversies-in-cll%252F&rts=13dcd17d7e0d12d1f7965a31fa3fdbb7fbb812ff","recaptchaV3Loaded":false,"recaptchaV2Loaded":false,"likesLoaded":false,"commentLikeMap":{},"commentOffset":0},"episode":{"id":"pb23144895","idTag":"rhkkv","title":"Discussing the Role of MRD in CLL With Talal Hilal, MD","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf_300x300.png","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","previewContent":null,"content":"